언어 선택

HLA-A*0201 | B2M | TRI

제품 문의

시판 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	가장 빠른 브랜드 이름	가장 빠른 승인 국가	가장 빠른 적응증	가장 빠른 승인 회사	가장 빠른 승인 날짜	적응증	임상 시험
Interferon beta (Toray/Daiichi Sankyo)	DL-8234	Approved		Feron	Japan	Hepatitis C; Astrocytoma; Glioblastoma; Hepatitis B; Medulloblastoma; Melanoma	null	1985-04-01	Medulloblastoma; Glioblastoma; Hepatitis B; Hepatitis C; Astrocytoma; Melanoma	상세
Recombinant human interferon alfa-2b (Harbin Pharmaceutical Group Bioengineering)		Approved	Harbin Pharmaceutical Group Holding Co Ltd	里亚美, 利分能	Mainland China	Condylomata Acuminata; Varicella Zoster Virus Infection; Leukemia, Hairy Cell; Leukemia, Myelogenous, Chronic; Lymphoma, Non-Hodgkin; Multiple Myeloma; Hepatitis, Viral, Human	Harbin Pharmaceutical Group Pharmaceutical Co Ltd	1996-01-01	Leukemia, Myelogenous, Chronic; Leukemia, Hairy Cell; Varicella Zoster Virus Infection; Multiple Myeloma; Hepatitis, Viral, Human; Lymphoma, Non-Hodgkin; Condylomata Acuminata	상세
Recombinant human interferon α2b biosimilar (Harbin High-Tech White Swan Pharmaceutical)		Approved	Harbin High-Tech Group Baitian'Er Pharmaceutical Co Ltd	Fu Li Sheng					Leukemia, Hairy Cell; Hepatitis; Multiple Myeloma; Leukemia, Myeloid, Chronic-Phase; Lymphoma, Non-Hodgkin; Herpes Zoster; Condylomata Acuminata	상세
Anifrolumab	MDX-1333; MEDI-546	Approved	Medimmune Llc, Medarex	SAPHNELO	United States	Lupus Erythematosus, Systemic	Astrazeneca Ab	2021-07-30	Polymyositis; Hidradenitis; Dermatomyositis; Myositis; Atherosclerosis; Scleroderma, Systemic; Lupus Erythematosus, Cutaneous; Sjogren's Syndrome; Autoimmune Diseases; Lupus Nephritis; Lupus Erythematosus, Systemic; Cardiovascular Diseases; Hidradenitis Suppurativa; Vitiligo	상세
Recombinant human interferon α2b biosimilar (Zhejiang Hansheng)		Approved	Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma	莱福隆	Mainland China	Neoplasms; Virus Diseases	Zhejiang Hansheng Pharmaceutical Co Ltd Of Beisheng Pharma	1999-01-01	Neoplasms; Virus Diseases	상세